Meeting
2021 Genitourinary Cancers Symposium
Does the diagnostic modality for upper tract urothelial carcinoma prior to radical nephroureterectomy influence the risk of subsequent intravesical recurrence?
Authors
Tanner Miest
MD Anderson Cancer Center, Houston, TX
Tanner Miest , Vidit Sharma , Tristan Juvet , Amir Toussi , Stephen A. Boorjian , Matthew K. Tollefson , Igor Frank , Aaron M. Potretzke
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Diagnostics
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 405)
DOI
10.1200/JCO.2021.39.6_suppl.405
Abstract #
405
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Gastric microbiome signature to predict metachronous recurrence after endoscopic resection of gastric neoplasms.
First Author: Hokyoung Lee
Poster
2023 ASCO Annual Meeting
A phase 3 multicenter study to evaluate the safety and efficacy of padeliporfin vascular targeted photodynamic therapy (VTP) in treatment of low-grade (LG) upper tract urothelial cancer (UTUC).
First Author: Jonathan Coleman
Poster
2023 ASCO Genitourinary Cancers Symposium
The impact of blue light cystoscopy use among patients with non-muscle invasive bladder cancer in an equal access setting.
First Author: Sanjay Das
Poster
2021 Genitourinary Cancers Symposium
Treatment results from a phase I study of WST11 phototherapy (VTP) for upper tract urothelial carcinoma.
First Author: Lucas Nogueira